A Potent Tumor-Reactive P53-Specific Single-Chain TCR Without On- Or Off-Target Autoimmunity in Vivo

Molecular Therapy - United States
doi 10.1016/j.ymthe.2018.11.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PUMA, a Potent Killer With or Without P53

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

Asialoglycoprotein Receptor (ASGPR): A Peculiar Target of Liver-Specific Autoimmunity

Autoimmunity Highlights
RheumatologyImmunology
2012English

Quaternary Structures of Tumor Suppressor P53 and a Specific P53 DNA Complex

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

The C Terminus of P53 Regulates Gene Expression by Multiple Mechanisms in a Target- And Tissue-Specific Manner in Vivo

Genes and Development
GeneticsDevelopmental Biology
2013English

Shortening the Ex Vivo Culture of CD19‐specific CAR T‐cells Retains Potent Efficacy Against Acute Lymphoblastic Leukemia Without CRES or Severe CRS

American Journal of Hematology
Hematology
2019English

In Vivo Selection of Tumor-Specific Antibodies

Oncotarget
Oncology
2013English

The Double Role of P53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Off-Target Effects of siRNA Specific for GFP

BMC Molecular Biology
Molecular Biology
2008English

Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in Vivo Tumor Targeting and Imaging

Small
Materials ScienceNanoscienceEngineeringBiomaterialsMedicineBiotechnologyNanotechnologyChemistry
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy